Eintrag weiter verarbeiten
Utilization of herpes simplex PCR assays for cerebrospinal fluid in a pediatric health care setting
Gespeichert in:
Zeitschriftentitel: | Canadian Journal of Microbiology |
---|---|
Personen und Körperschaften: | , , , |
In: | Canadian Journal of Microbiology, 47, 2001, 5, S. 392-396 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
Canadian Science Publishing
|
Schlagwörter: |
author_facet |
Cimolai, Nevio Thomas, Eva E Tan, Rusung Hill, Alan Cimolai, Nevio Thomas, Eva E Tan, Rusung Hill, Alan |
---|---|
author |
Cimolai, Nevio Thomas, Eva E Tan, Rusung Hill, Alan |
spellingShingle |
Cimolai, Nevio Thomas, Eva E Tan, Rusung Hill, Alan Canadian Journal of Microbiology Utilization of herpes simplex PCR assays for cerebrospinal fluid in a pediatric health care setting Genetics Molecular Biology Applied Microbiology and Biotechnology General Medicine Immunology Microbiology |
author_sort |
cimolai, nevio |
spelling |
Cimolai, Nevio Thomas, Eva E Tan, Rusung Hill, Alan 0008-4166 1480-3275 Canadian Science Publishing Genetics Molecular Biology Applied Microbiology and Biotechnology General Medicine Immunology Microbiology http://dx.doi.org/10.1139/w01-028 <jats:p>An assessment was made of the utilization and impact of a diagnostic polymerase chain reaction (PCR) assay for the diagnosis of herpes simplex viruses (HSV) 1 and 2 in cerebrospinal fluid of children who attended a Canadian pediatric referral centre. One hundred and three assays were performed on specimens from 103 patients during the period August 1997 to September 1998. Patient ages ranged from newborn to 16 years. Indications for HSV PCR included seizures with or without fever (56.3%), aseptic meningitis (16.5%), and encephalopathy with or without fever (10.7%). Only 2 of 103 (1.9%) assays were positive, including one each for HSV1 and HSV2. Control specimens that were seeded with virus indicated inhibition for 24.3, 8.8, and 6.8% of assays for HSV1, HSV2, and both HSV1 and HSV2, respectively. The mean turn-around time for HSV PCR was 2.5 days, and 90.3% were completed in less than 5 days. Acyclovir was administered to 78.6% of the patients overall; the results of the HSV PCR impacted on the treatment courses for 36 individuals. Nevertheless, 16.5% of patients continued to receive extended courses of antiviral therapy despite negative HSV PCR assays. Although it is desirable to decrease the frequency of PCR inhibitions and to further decrease the interval to assay completion, HSV PCR does have a significant impact on antiviral use in this setting.Key words: herpes simplex, polymerase chain reaction, central nervous system.</jats:p> Utilization of herpes simplex PCR assays for cerebrospinal fluid in a pediatric health care setting Canadian Journal of Microbiology |
doi_str_mv |
10.1139/w01-028 |
facet_avail |
Online |
finc_class_facet |
Biologie Technik Medizin |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEzOS93MDEtMDI4 |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEzOS93MDEtMDI4 |
institution |
DE-Zi4 DE-Gla1 DE-15 DE-Pl11 DE-Rs1 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-D161 |
imprint |
Canadian Science Publishing, 2001 |
imprint_str_mv |
Canadian Science Publishing, 2001 |
issn |
0008-4166 1480-3275 |
issn_str_mv |
0008-4166 1480-3275 |
language |
English |
mega_collection |
Canadian Science Publishing (CrossRef) |
match_str |
cimolai2001utilizationofherpessimplexpcrassaysforcerebrospinalfluidinapediatrichealthcaresetting |
publishDateSort |
2001 |
publisher |
Canadian Science Publishing |
recordtype |
ai |
record_format |
ai |
series |
Canadian Journal of Microbiology |
source_id |
49 |
title |
Utilization of herpes simplex PCR assays for cerebrospinal fluid in a pediatric health care setting |
title_unstemmed |
Utilization of herpes simplex PCR assays for cerebrospinal fluid in a pediatric health care setting |
title_full |
Utilization of herpes simplex PCR assays for cerebrospinal fluid in a pediatric health care setting |
title_fullStr |
Utilization of herpes simplex PCR assays for cerebrospinal fluid in a pediatric health care setting |
title_full_unstemmed |
Utilization of herpes simplex PCR assays for cerebrospinal fluid in a pediatric health care setting |
title_short |
Utilization of herpes simplex PCR assays for cerebrospinal fluid in a pediatric health care setting |
title_sort |
utilization of herpes simplex pcr assays for cerebrospinal fluid in a pediatric health care setting |
topic |
Genetics Molecular Biology Applied Microbiology and Biotechnology General Medicine Immunology Microbiology |
url |
http://dx.doi.org/10.1139/w01-028 |
publishDate |
2001 |
physical |
392-396 |
description |
<jats:p>An assessment was made of the utilization and impact of a diagnostic polymerase chain reaction (PCR) assay for the diagnosis of herpes simplex viruses (HSV) 1 and 2 in cerebrospinal fluid of children who attended a Canadian pediatric referral centre. One hundred and three assays were performed on specimens from 103 patients during the period August 1997 to September 1998. Patient ages ranged from newborn to 16 years. Indications for HSV PCR included seizures with or without fever (56.3%), aseptic meningitis (16.5%), and encephalopathy with or without fever (10.7%). Only 2 of 103 (1.9%) assays were positive, including one each for HSV1 and HSV2. Control specimens that were seeded with virus indicated inhibition for 24.3, 8.8, and 6.8% of assays for HSV1, HSV2, and both HSV1 and HSV2, respectively. The mean turn-around time for HSV PCR was 2.5 days, and 90.3% were completed in less than 5 days. Acyclovir was administered to 78.6% of the patients overall; the results of the HSV PCR impacted on the treatment courses for 36 individuals. Nevertheless, 16.5% of patients continued to receive extended courses of antiviral therapy despite negative HSV PCR assays. Although it is desirable to decrease the frequency of PCR inhibitions and to further decrease the interval to assay completion, HSV PCR does have a significant impact on antiviral use in this setting.Key words: herpes simplex, polymerase chain reaction, central nervous system.</jats:p> |
container_issue |
5 |
container_start_page |
392 |
container_title |
Canadian Journal of Microbiology |
container_volume |
47 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792326848496009230 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T12:27:40.945Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Utilization+of+herpes+simplex+PCR+assays+for+cerebrospinal+fluid+in+a+pediatric+health+care+setting&rft.date=2001-05-01&genre=article&issn=1480-3275&volume=47&issue=5&spage=392&epage=396&pages=392-396&jtitle=Canadian+Journal+of+Microbiology&atitle=Utilization+of+herpes+simplex+PCR+assays+for+cerebrospinal+fluid+in+a+pediatric+health+care+setting&aulast=Hill&aufirst=Alan&rft_id=info%3Adoi%2F10.1139%2Fw01-028&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792326848496009230 |
author | Cimolai, Nevio, Thomas, Eva E, Tan, Rusung, Hill, Alan |
author_facet | Cimolai, Nevio, Thomas, Eva E, Tan, Rusung, Hill, Alan, Cimolai, Nevio, Thomas, Eva E, Tan, Rusung, Hill, Alan |
author_sort | cimolai, nevio |
container_issue | 5 |
container_start_page | 392 |
container_title | Canadian Journal of Microbiology |
container_volume | 47 |
description | <jats:p>An assessment was made of the utilization and impact of a diagnostic polymerase chain reaction (PCR) assay for the diagnosis of herpes simplex viruses (HSV) 1 and 2 in cerebrospinal fluid of children who attended a Canadian pediatric referral centre. One hundred and three assays were performed on specimens from 103 patients during the period August 1997 to September 1998. Patient ages ranged from newborn to 16 years. Indications for HSV PCR included seizures with or without fever (56.3%), aseptic meningitis (16.5%), and encephalopathy with or without fever (10.7%). Only 2 of 103 (1.9%) assays were positive, including one each for HSV1 and HSV2. Control specimens that were seeded with virus indicated inhibition for 24.3, 8.8, and 6.8% of assays for HSV1, HSV2, and both HSV1 and HSV2, respectively. The mean turn-around time for HSV PCR was 2.5 days, and 90.3% were completed in less than 5 days. Acyclovir was administered to 78.6% of the patients overall; the results of the HSV PCR impacted on the treatment courses for 36 individuals. Nevertheless, 16.5% of patients continued to receive extended courses of antiviral therapy despite negative HSV PCR assays. Although it is desirable to decrease the frequency of PCR inhibitions and to further decrease the interval to assay completion, HSV PCR does have a significant impact on antiviral use in this setting.Key words: herpes simplex, polymerase chain reaction, central nervous system.</jats:p> |
doi_str_mv | 10.1139/w01-028 |
facet_avail | Online |
finc_class_facet | Biologie, Technik, Medizin |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEzOS93MDEtMDI4 |
imprint | Canadian Science Publishing, 2001 |
imprint_str_mv | Canadian Science Publishing, 2001 |
institution | DE-Zi4, DE-Gla1, DE-15, DE-Pl11, DE-Rs1, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161 |
issn | 0008-4166, 1480-3275 |
issn_str_mv | 0008-4166, 1480-3275 |
language | English |
last_indexed | 2024-03-01T12:27:40.945Z |
match_str | cimolai2001utilizationofherpessimplexpcrassaysforcerebrospinalfluidinapediatrichealthcaresetting |
mega_collection | Canadian Science Publishing (CrossRef) |
physical | 392-396 |
publishDate | 2001 |
publishDateSort | 2001 |
publisher | Canadian Science Publishing |
record_format | ai |
recordtype | ai |
series | Canadian Journal of Microbiology |
source_id | 49 |
spelling | Cimolai, Nevio Thomas, Eva E Tan, Rusung Hill, Alan 0008-4166 1480-3275 Canadian Science Publishing Genetics Molecular Biology Applied Microbiology and Biotechnology General Medicine Immunology Microbiology http://dx.doi.org/10.1139/w01-028 <jats:p>An assessment was made of the utilization and impact of a diagnostic polymerase chain reaction (PCR) assay for the diagnosis of herpes simplex viruses (HSV) 1 and 2 in cerebrospinal fluid of children who attended a Canadian pediatric referral centre. One hundred and three assays were performed on specimens from 103 patients during the period August 1997 to September 1998. Patient ages ranged from newborn to 16 years. Indications for HSV PCR included seizures with or without fever (56.3%), aseptic meningitis (16.5%), and encephalopathy with or without fever (10.7%). Only 2 of 103 (1.9%) assays were positive, including one each for HSV1 and HSV2. Control specimens that were seeded with virus indicated inhibition for 24.3, 8.8, and 6.8% of assays for HSV1, HSV2, and both HSV1 and HSV2, respectively. The mean turn-around time for HSV PCR was 2.5 days, and 90.3% were completed in less than 5 days. Acyclovir was administered to 78.6% of the patients overall; the results of the HSV PCR impacted on the treatment courses for 36 individuals. Nevertheless, 16.5% of patients continued to receive extended courses of antiviral therapy despite negative HSV PCR assays. Although it is desirable to decrease the frequency of PCR inhibitions and to further decrease the interval to assay completion, HSV PCR does have a significant impact on antiviral use in this setting.Key words: herpes simplex, polymerase chain reaction, central nervous system.</jats:p> Utilization of herpes simplex PCR assays for cerebrospinal fluid in a pediatric health care setting Canadian Journal of Microbiology |
spellingShingle | Cimolai, Nevio, Thomas, Eva E, Tan, Rusung, Hill, Alan, Canadian Journal of Microbiology, Utilization of herpes simplex PCR assays for cerebrospinal fluid in a pediatric health care setting, Genetics, Molecular Biology, Applied Microbiology and Biotechnology, General Medicine, Immunology, Microbiology |
title | Utilization of herpes simplex PCR assays for cerebrospinal fluid in a pediatric health care setting |
title_full | Utilization of herpes simplex PCR assays for cerebrospinal fluid in a pediatric health care setting |
title_fullStr | Utilization of herpes simplex PCR assays for cerebrospinal fluid in a pediatric health care setting |
title_full_unstemmed | Utilization of herpes simplex PCR assays for cerebrospinal fluid in a pediatric health care setting |
title_short | Utilization of herpes simplex PCR assays for cerebrospinal fluid in a pediatric health care setting |
title_sort | utilization of herpes simplex pcr assays for cerebrospinal fluid in a pediatric health care setting |
title_unstemmed | Utilization of herpes simplex PCR assays for cerebrospinal fluid in a pediatric health care setting |
topic | Genetics, Molecular Biology, Applied Microbiology and Biotechnology, General Medicine, Immunology, Microbiology |
url | http://dx.doi.org/10.1139/w01-028 |